newsfilter
← Latest News
GlobeNewswire·

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and